Header Logo

Connection

Ricardo Gazzinelli to CD4-Positive T-Lymphocytes

This is a "connection" page, showing publications Ricardo Gazzinelli has written about CD4-Positive T-Lymphocytes.
  1. Henriques PM, Almeida GG, Rimkute I, Dos Santos LI, Liechti T, Marino AP, do Vale INPC, Vasconcelos-Santos DV, Martins-Filho OA, Gazzinelli RT, Roederer M, Sher A, Teixeira-Carvalho A, Jankovic D, Antonelli LRDV. Cytotoxic Signature and IFN-? Production Dominate CD4+ T-Cell Response During Human Toxoplasmosis. Immunology. 2025 Jun; 175(2):151-164.
    View in: PubMed
    Score: 0.175
  2. de Faria PC, dos Santos LI, Coelho JP, Ribeiro HB, Pimenta MA, Ladeira LO, Gomes DA, Furtado CA, Gazzinelli RT. Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8(+) T cell response and protection against cancer. Nano Lett. 2014 Sep 10; 14(9):5458-70.
    View in: PubMed
    Score: 0.084
  3. Dutra MS, B?la SR, Peixoto-Rangel AL, Fakiola M, Cruz AG, Gazzinelli A, Quites HF, Bahia-Oliveira LM, Peixe RG, Campos WR, Higino-Rocha AC, Miller NE, Blackwell JM, Antonelli LR, Gazzinelli RT. Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis. 2013 Jan 01; 207(1):152-63.
    View in: PubMed
    Score: 0.074
  4. Fernandes AP, Coelho EA, Machado-Coelho GL, Grimaldi G, Gazzinelli RT. Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives. Curr Opin Microbiol. 2012 Aug; 15(4):476-85.
    View in: PubMed
    Score: 0.072
  5. Junqueira C, Guerrero AT, Galv?o-Filho B, Andrade WA, Salgado AP, Cunha TM, Ropert C, Campos MA, Penido ML, Mendon?a-Previato L, Previato JO, Ritter G, Cunha FQ, Gazzinelli RT. Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine. PLoS One. 2012; 7(5):e36245.
    View in: PubMed
    Score: 0.072
  6. Junqueira C, Santos LI, Galv?o-Filho B, Teixeira SM, Rodrigues FG, DaRocha WD, Chiari E, Jungbluth AA, Ritter G, Gnjatic S, Old LJ, Gazzinelli RT. Trypanosoma cruzi as an effective cancer antigen delivery vector. Proc Natl Acad Sci U S A. 2011 Dec 06; 108(49):19695-700.
    View in: PubMed
    Score: 0.070
  7. de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, Lannes-Vieira J, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun. 2009 Oct; 77(10):4383-95.
    View in: PubMed
    Score: 0.059
  8. Resende DM, Caetano BC, Dutra MS, Penido ML, Abrantes CF, Verly RM, Resende JM, Pil?-Veloso D, Rezende SA, Bruna-Romero O, Fernandes AP, Gazzinelli RT. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Vaccine. 2008 Aug 18; 26(35):4585-93.
    View in: PubMed
    Score: 0.055
  9. de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 Sep; 19(9):e0013554.
    View in: PubMed
    Score: 0.045
  10. Almeida GG, Costa CM, Costa PAC, Gomes GR, Figueiredo MM, Torres KJ, de Carvalho AF, Valiate BVS, Sampaio JR, Carvalho BC, Pereira DB, Martines A, Tada MS, Soares IS, Ponmattam J, Castro MC, Golenbock DT, Gazzinelli RT, Antonelli LRDV. Asymptomatic vivax malaria is associated with an IFN-?-program on adaptive immunity. J Transl Med. 2025 Mar 19; 23(1):351.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.